AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2025
Aug 18, 2025
33003_dirs_2025-08-18_491c4086-aa0c-48ee-8808-c42ca7d7435f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-08-14
Reporting Person: Howton David T (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | Employee Stock Option (Right to Buy) | $6.17 | A | 150000 | Acquired | 2035-08-14 | Common Stock (150000) | Direct |
| 2025-08-14 | Restricted Stock Units | $ | A | 75000 | Acquired | Common Stock (75000) | Direct |
Footnotes
F1: The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.
F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19